CNBC Pro

Moderna, Nio, Carrier: CNBC’s Halftime Report traders answer your questions on these stocks

The Moderna COVID-19 vaccine.
Paul Hennessy | LightRocket | Getty Images

CNBC's "Halftime Report" traders answered questions from CNBC Pro subscribers, including how to approach investing in Moderna, whether to buy U.S.-listed Chinese stocks like Nio, and if home appliances company Carrier Global is a name to hold in the long term.

More In CNBC TV Picks

Wharton's Jeremy Siegel says the market bottom is in and a 'soft landing' is still possible
CNBC ProWharton's Jeremy Siegel says the market bottom is in and a 'soft landing' is still possible
Mohamed El-Erian says Fed should keep focus on inflation even with economy 'weakening really fast'
CNBC ProMohamed El-Erian says Fed should keep focus on inflation even with economy 'weakening really fast'
Dan Niles dumps internet stocks ahead of an 'ugly' week of earnings
CNBC ProDan Niles dumps internet stocks ahead of an 'ugly' week of earnings